FDA recall record

THERAKOS CELLEX Photopheresis Procedural Kit PRODUCT CODE: CLXUSA recall — FDA Z-0212-2022

Product was released prior to all testing being completed. If used and a drive tube leak were to occur, may cause illness or injury.

Class IIclassification
Z-0212-2022official record ID
Nov 17, 2021report date

Recall record at a glance

Official recordZ-0212-2022
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmTherakos, Inc.
Report dateNov 17, 2021
Recall initiation dateOct 4, 2021
QuantityFive (5) Cases -3 Kits/Case= 15 Kits
LocationWest Chester, PA, United States

Official product description

THERAKOS CELLEX Photopheresis Procedural Kit PRODUCT CODE: CLXUSA

Why the product was recalled

Product was released prior to all testing being completed. If used and a drive tube leak were to occur, may cause illness or injury.

Distribution information

IL

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.